Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association

JJ Joseph, P Deedwania, T Acharya, D Aguilar… - Circulation, 2022 - Am Heart Assoc
Cardiovascular disease remains the leading cause of death in patients with diabetes.
Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk …

Genetics of diabetes mellitus and diabetes complications

JB Cole, JC Florez - Nature reviews nephrology, 2020 - nature.com
Diabetes is one of the fastest growing diseases worldwide, projected to affect 693 million
adults by 2045. Devastating macrovascular complications (cardiovascular disease) and …

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

M Kinoshita, K Yokote, H Arai, M Iida… - … of atherosclerosis and …, 2018 - jstage.jst.go.jp
Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

Type 2 diabetes mellitus

RA DeFronzo, E Ferrannini, L Groop… - Nature reviews Disease …, 2015 - nature.com
Type 2 diabetes mellitus (T2DM) is an expanding global health problem, closely linked to
the epidemic of obesity. Individuals with T2DM are at high risk for both microvascular …

Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus

K Nakamura, T Miyoshi, M Yoshida, S Akagi… - International journal of …, 2022 - mdpi.com
There is a close relationship between diabetes mellitus and heart failure, and diabetes is an
independent risk factor for heart failure. Diabetes and heart failure are linked by not only the …

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

SJ Griffin, JK Leaver, GJ Irving - Diabetologia, 2017 - Springer
Aims/hypothesis Metformin is the most-prescribed oral medication to lower blood glucose
worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in …

Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart …

CS Fox, SH Golden, C Anderson, GA Bray, LE Burke… - Circulation, 2015 - Am Heart Assoc
Cardiovascular disease risk factor control as primary prevention in patients with type 2
diabetes mellitus has changed substantially in the past few years. The purpose of this …

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised …

S Zoungas, H Arima, HC Gerstein… - The lancet Diabetes & …, 2017 - thelancet.com
Background Intensive glucose control is understood to prevent complications in adults with
type 2 diabetes. We aimed to more precisely estimate the effects of more intensive glucose …

Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart …

J Rangaswami, V Bhalla, IH De Boer, A Staruschenko… - Circulation, 2020 - Am Heart Assoc
Chronic kidney disease (CKD) with type 2 diabetes (T2D) is a major public health problem,
resulting in significant cardiovascular and kidney adverse outcomes worldwide. Despite the …

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

MC Thomas, ME Cooper, P Zimmet - Nature Reviews Nephrology, 2016 - nature.com
Chronic kidney disease (CKD) is a common comorbidity in patients with type 2 diabetes
mellitus (T2DM) and both conditions are increasing in prevalence. CKD is estimated to …